The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Riedell, Peter
One or more keywords matched the following items that are connected to Riedell, Peter
Item TypeName
Concept Lymphoma, Mantle-Cell
Concept Lymphoma, B-Cell
Academic Article Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.
Academic Article Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
Academic Article A drug safety evaluation of rituximab and risk of hepatitis B.
Academic Article Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.
Academic Article Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.
Academic Article Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy.
Academic Article Double hit and double expressors in lymphoma: Definition and treatment.
Academic Article Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.
Academic Article Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Academic Article Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Academic Article Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
Academic Article Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Academic Article Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL.
Academic Article Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Academic Article Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.
Academic Article Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Academic Article Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Academic Article A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Academic Article Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Search Criteria
  • Lymphoma T Cell